GB1426717A - Penicillins - Google Patents

Penicillins

Info

Publication number
GB1426717A
GB1426717A GB1169272A GB1169272A GB1426717A GB 1426717 A GB1426717 A GB 1426717A GB 1169272 A GB1169272 A GB 1169272A GB 1169272 A GB1169272 A GB 1169272A GB 1426717 A GB1426717 A GB 1426717A
Authority
GB
United Kingdom
Prior art keywords
compound
reacting
formula
acid
defined above
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1169272A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astra Lakemedel AB
Original Assignee
Astra Lakemedel AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Lakemedel AB filed Critical Astra Lakemedel AB
Priority to GB1169272A priority Critical patent/GB1426717A/en
Priority to DE2312041A priority patent/DE2312041A1/en
Priority to AU53209/73A priority patent/AU5320973A/en
Priority to JP48028906A priority patent/JPS49289A/ja
Priority to FR7308754A priority patent/FR2201870A1/fr
Priority to AT214273A priority patent/AT332540B/en
Priority to NL7303489A priority patent/NL7303489A/xx
Priority to DK543774A priority patent/DK543774A/da
Priority to NO750668A priority patent/NO750668L/no
Priority to AT632575A priority patent/AT332974B/en
Priority to SE7512141A priority patent/SE7512141L/en
Publication of GB1426717A publication Critical patent/GB1426717A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

1426717 Carbonic esters of penicillins ASTRA LAKEMEDEL AB 12 March 1973 [13 March 1972] 11692/72 Heading C2C [Also in Division A5] Novel penicillins comprise compounds of formula or pharmaceutically acceptable salts thereof, wherein R is phenyl, thienyl or furyl; R<SP>1</SP> is H or R<SP>2</SP> is as for R<SP>1</SP> or C 1 -C 8 alkyl, aryl or aralkyl; R<SP>3</SP> is H or CH 3 ; R<SP>4</SP> is a C 1 -C 8 alkyl, alkenyl or alkynyl, C 3 -C 7 cycloalkyl, phenyl, benzyl, indanyl, thienyl, furyl, furfuryl, pyridyl, pyridylmethyl or 2-methyl-1,3-dioxanyl group, these groups being optionally substituted with one or more amino, substituted amino or nitro groups or halogen; provided that R<SP>2</SP> is where R<SP>1</SP> is H. The compounds are prepared (a) by reacting 6-aminopenicillanic acid with a compound R<SP>7</SP>'Y, wherein R<SP>7</SP>' is R<SP>7</SP>, wherein R<SP>7</SP> is wherein R<SP>3</SP> and R<SP>4</SP> are as defined above or R<SP>7</SP>' is a protected R<SP>7</SP> group and Y is halogen or a functionally equivalent group, to provide esters of Formula IV wherein R<SP>7</SP>' is as defined above, which are reacted with a compound of formula wherein R is as defined above, R<SP>2</SP>' is R<SP>2</SP> or a protected R<SP>2</SP> group and -COZ is an amideforming group and, if necessary, removing protecting groups, or (b) by reacting an ester of formula wherein R‹CO is the acyl group of a natural or biosynthetic penicillin, and R<SP>7</SP> is as defined above with a phosphorus halide to form an imino halide, reacting this with a lower alcohol and reacting the imino ether produced with a compound of Formula III as above or (c) by esterifying a compound of formula wherein R and R<SP>2</SP> are as defined above with a compound R<SP>7</SP>'Y, wherein Y is an esterifying group or halogen and R<SP>7</SP>' is as defined above, or (d) by reacting a compound of formula wherein R and R<SP>2</SP>' are as defined above, with a compound of Formula IV as above, or (e) by esterifying a compound of formula wherein R is as defined above, Q is H or a cation and R<SP>8</SP>' is an R<SP>1</SP> or protected R<SP>1</SP> group, with a compound R<SP>6</SP>'Y, R<SP>6</SP>' being an R<SP>2</SP> or protected R<SP>2</SP> group, neither R<SP>1</SP> nor R<SP>2</SP> being H, or (f) by reacting a compound of formula wherein R is as defined above with a compound wherein R<SP>4</SP> is R<SP>4</SP>' as defined above or a protected R<SP>4</SP> group, and R<SP>3</SP> is as defined above or (g) by reacting a suitable activated malonic acid ester with 6-APA or (h) by reacting an α-carboxy, 3-protected carboxy penicillin with a compound of formula wherein Y, R<SP>3</SP> and R<SP>4</SP>' are as defined above or (i) by reacting a 6-N-acylated natural or biosynthetic penicillin having a protected carboxy group with a phosphorus halide to give an imino halide which is treated with a lower alcohol to give an imino ether, which is reacted with a suitable malonic acid ester derivative or (j) by reacting a compound of formula wherein R, R<SP>4</SP>' and R<SP>3</SP> have the above-defined meanings with 6-APA having the carboxy group protected or (k) by reacting an acid α-carboxy 6-acylated penicillanic with a compound of formula wherein Y, R<SP>3</SP>, X and R<SP>4</SP>' have the meanings defined above to yield a mixture of compounds of formulae wherein R, R<SP>3</SP> and R<SP>4</SP> have the above meanings. Chloromethylethyl carbonate is prepared by reacting chloromethyl chloroformate with ethanol and is then reacted with potassium phenylacetate to form ethoxycarbonyloxymethylphenyacetate, from which phenylmalonic acid ethoxycarbonyloxymethyl monoester is prepared by reaction with dry ice (CO 2 ) in the presence of n-butyllithium. The acid chloride of the monoester is prepared by reaction with thionyl chloride. Ethoxycarbonyloxymethyl - (3 - thienyl) - acetate, 3- thienylmalonic acid ethoxycarbonyloxymethyl monoester, its acid chloride, chloromethylphenyl carbonate, phenylacetic acid phenoxycarbonyloxymethyl ester, its acid chloride, phenylmalonic acid phenoxycarbonyloxymethyl monoester, its acid chloride, chloromethyl-2-N- benzyloxycarbonylmethylamino ethyl carbonate, and α - chloroethylcyclopentyl carbonate are produced by similar methods 3-thienylacetic acid acid chloride is produced by reacting 3-thienylacetic acid with thionyl chloride and the product is esterified to yield benzyl-(3-thienyl) acetate. N-benzyloxycarbonyl methylamino ethanol is prepared by reacting chloroformic acid with 2 - methyamino ethanol. Phenylmalonic acid (1<SP>1</SP> - ethoxycarbonyloxyethyl)monoester is produced from the diester by hydrogenation, the diester being produced by methods similar to those above. Pharmaceutical compositions comprise a compound of the invention and a pharmaceutically acceptable carrier. Other antibiotics may be present (see Division A5).
GB1169272A 1972-03-13 1972-03-13 Penicillins Expired GB1426717A (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GB1169272A GB1426717A (en) 1972-03-13 1972-03-13 Penicillins
DE2312041A DE2312041A1 (en) 1972-03-13 1973-03-10 PENICILLIN, THE METHOD OF MANUFACTURING THEIR PRODUCTS AND THE PHARMACEUTICAL PRODUCTS CONTAINING IT
AU53209/73A AU5320973A (en) 1972-03-13 1973-03-12 Penicillins
JP48028906A JPS49289A (en) 1972-03-13 1973-03-12
FR7308754A FR2201870A1 (en) 1972-03-13 1973-03-12
AT214273A AT332540B (en) 1972-03-13 1973-03-12 METHOD FOR MANUFACTURING NEW PENICILLIN
NL7303489A NL7303489A (en) 1972-03-13 1973-03-13
DK543774A DK543774A (en) 1972-03-13 1974-10-17
NO750668A NO750668L (en) 1972-03-13 1975-02-27
AT632575A AT332974B (en) 1972-03-13 1975-08-14 METHOD FOR MANUFACTURING NEW PENICILLIN
SE7512141A SE7512141L (en) 1972-03-13 1975-10-30 NEW ORGANIC ASSOCIATIONS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1169272A GB1426717A (en) 1972-03-13 1972-03-13 Penicillins

Publications (1)

Publication Number Publication Date
GB1426717A true GB1426717A (en) 1976-03-03

Family

ID=9990955

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1169272A Expired GB1426717A (en) 1972-03-13 1972-03-13 Penicillins

Country Status (9)

Country Link
JP (1) JPS49289A (en)
AT (1) AT332540B (en)
AU (1) AU5320973A (en)
DE (1) DE2312041A1 (en)
FR (1) FR2201870A1 (en)
GB (1) GB1426717A (en)
NL (1) NL7303489A (en)
NO (1) NO750668L (en)
SE (1) SE7512141L (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4606865A (en) * 1982-09-20 1986-08-19 Astra Lakemedel Aktiebolag Methods for the preparation of α-bromodiethylcarbonate
US4614829A (en) * 1983-08-26 1986-09-30 Societe Nationale Des Poudres Et Explosifs Process for the preparation of α-chlorinated chloroformates
US4619785A (en) * 1982-06-29 1986-10-28 Astra Lakemedel Aktiebolag Novel synthesis route for bacampicillin
US4960881A (en) * 1984-02-16 1990-10-02 Societe Nationale Des Poudres Et Explosifs α-chlorinated carbonates, their method of manufacture and application in the protection of the amine functions of amino acids
WO2004067536A2 (en) * 2003-01-28 2004-08-12 Sandoz Ag Carboxylic acid esters to improve bioavailability of pharmaceutical compounds
US7091197B2 (en) 2002-08-23 2006-08-15 Pfizer Inc. Beta-lactamase inhibitor prodrug

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2482587A1 (en) * 1980-05-14 1981-11-20 Poudres & Explosifs Ste Nale PROCESS FOR THE SYNTHESIS OF A-CHLORINATED CHLOROFORMIATES AND NEW A-CHLORINATED CHLOROFORMIATES
IL68992A (en) * 1982-06-29 1991-06-10 Astra Laekemedel Ab Alpha-bromo diethyl carbonate and process for the preparation of ethoxycarbonyloxy esters of penicillanic acids
GB8400024D0 (en) * 1984-01-03 1984-02-08 Glaxo Group Ltd Cephalosporin antibiotics
FR2559766B1 (en) * 1984-02-16 1986-05-16 Poudres & Explosifs Ste Nale PROCESS FOR THE PREPARATION OF CARBAMIC ACID DERIVATIVES
US4916230A (en) * 1984-07-02 1990-04-10 Merck & Co., Inc. Process for preparing novel N-(acyloxy-alkoxy)carbonyl derivatives useful as bioreversible prodrug moieties for primary and secondary amine functions in drugs

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619785A (en) * 1982-06-29 1986-10-28 Astra Lakemedel Aktiebolag Novel synthesis route for bacampicillin
US4606865A (en) * 1982-09-20 1986-08-19 Astra Lakemedel Aktiebolag Methods for the preparation of α-bromodiethylcarbonate
US4820857A (en) * 1982-09-20 1989-04-11 Astra Lakemedel Aktiebolag α-bromodiethylcarbonate
US4614829A (en) * 1983-08-26 1986-09-30 Societe Nationale Des Poudres Et Explosifs Process for the preparation of α-chlorinated chloroformates
US4960881A (en) * 1984-02-16 1990-10-02 Societe Nationale Des Poudres Et Explosifs α-chlorinated carbonates, their method of manufacture and application in the protection of the amine functions of amino acids
US7091197B2 (en) 2002-08-23 2006-08-15 Pfizer Inc. Beta-lactamase inhibitor prodrug
WO2004067536A2 (en) * 2003-01-28 2004-08-12 Sandoz Ag Carboxylic acid esters to improve bioavailability of pharmaceutical compounds
WO2004067536A3 (en) * 2003-01-28 2004-12-23 Sandoz Ag Carboxylic acid esters to improve bioavailability of pharmaceutical compounds

Also Published As

Publication number Publication date
NL7303489A (en) 1973-09-17
DE2312041A1 (en) 1973-10-11
AU5320973A (en) 1974-09-12
FR2201870A1 (en) 1974-05-03
AT332540B (en) 1976-10-11
SE7512141L (en) 1975-10-30
ATA214273A (en) 1976-01-15
NO750668L (en) 1973-09-14
JPS49289A (en) 1974-01-05

Similar Documents

Publication Publication Date Title
GB1426717A (en) Penicillins
GB1348199A (en) Acylaminopenicillanic acid derivatives
US3954733A (en) Naphthyridine-3-carboxamido-benzylpenicillins and salts thereof
ES411163A1 (en) Penicillin and cephalosporin compounds
GB1364453A (en) Penicillanic and cepholosporanic acid derivatives
GB1425571A (en) Penicillins and cephaosporins
IE39741B1 (en) Phenyl-benzoig acid deritavies
GB1426869A (en) Penicillins
IE34181B1 (en) New cephalosporins useful as intermediates in making cephalexin and improved process for the synthesis of cephalexin
GB1339605A (en) Penicillin synthesis
GB1425827A (en) Penicillins and cephalosporins
GB1433131A (en) Penicillins
GB1390754A (en) Penicillin and cephalosporin esters
US4308259A (en) Penicillin derivatives
EP0043205B1 (en) Penicillin derivatives
US4088656A (en) Oxoclavams
GB1334035A (en) 6-aminopenicillanic acid derivatives and a process for the manufacture thereof
EP0066373B1 (en) Beta-lactam derivatives, a process for their preparation and compositions containing them
EP0093564B1 (en) Beta-lactam antibiotics
GB1261780A (en) Orally active sulfur-containing cephalosporin antibiotics
GB1464551A (en) Alpha-substituted amino-phenylacetamido penicillanic acid and cephalosporanic acid derivatives methods for their preparation and their use
GB1426557A (en) Production of substituted monomalonate esters and their use in the production of alpha-carboxy penicillins and cephalosporins
GB1421526A (en) Penicillins and cephalosporins
GB1476312A (en) Penicillins and cephalosporins
GB1389540A (en) Derivatives of alpha-aminocephalosporins

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PLNP Patent lapsed through nonpayment of renewal fees